NSUN5 and glioblastoma: To determine whether this is the case in GBM cells, we used CRISPR/Cas9 to generate NSUN5 knockout (KO) and wild‐type (WT) clones in U251 cells, which was confirmed by genomic DNA sequencing (Fig. S2A) and Western blotting (Fig. 2A).